Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Basic): 2009-2025

Historic EPS (Basic) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $0.86.

  • Prestige Consumer Healthcare's EPS (Basic) fell 21.82% to $0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.06, marking a year-over-year decrease of 2.17%. This contributed to the annual value of $4.32 for FY2025, which is 2.61% up from last year.
  • According to the latest figures from Q3 2025, Prestige Consumer Healthcare's EPS (Basic) is $0.86, which was down 10.42% from $0.96 recorded in Q2 2025.
  • Prestige Consumer Healthcare's EPS (Basic)'s 5-year high stood at $1.23 during Q4 2024, with a 5-year trough of -$4.82 in Q1 2023.
  • Over the past 3 years, Prestige Consumer Healthcare's median EPS (Basic) value was $1.01 (recorded in 2025), while the average stood at $0.50.
  • In the last 5 years, Prestige Consumer Healthcare's EPS (Basic) tumbled by 563.46% in 2023 and then skyrocketed by 120.75% in 2024.
  • Prestige Consumer Healthcare's EPS (Basic) (Quarterly) stood at $1 in 2021, then increased by 5.00% to $1.05 in 2022, then climbed by 1.90% to $1.07 in 2023, then climbed by 14.95% to $1.23 in 2024, then decreased by 21.82% to $0.86 in 2025.
  • Its EPS (Basic) was $0.86 in Q3 2025, compared to $0.96 in Q2 2025 and $1.01 in Q1 2025.